Centiva Capital LP Reduces Stake in Privia Health Group, Inc. (NASDAQ:PRVA)

Centiva Capital LP lowered its stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 41.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 24,289 shares of the company's stock after selling 17,325 shares during the period. Centiva Capital LP's holdings in Privia Health Group were worth $475,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in PRVA. Riverbridge Partners LLC boosted its position in Privia Health Group by 19.7% during the 4th quarter. Riverbridge Partners LLC now owns 5,824,458 shares of the company's stock worth $113,868,000 after acquiring an additional 958,418 shares during the last quarter. Loomis Sayles & Co. L P boosted its position in Privia Health Group by 55.0% during the 4th quarter. Loomis Sayles & Co. L P now owns 1,418,234 shares of the company's stock worth $27,727,000 after acquiring an additional 503,002 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in Privia Health Group by 10.9% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,416,235 shares of the company's stock worth $27,687,000 after acquiring an additional 138,747 shares during the last quarter. Northern Trust Corp raised its stake in shares of Privia Health Group by 14.2% during the 4th quarter. Northern Trust Corp now owns 1,392,641 shares of the company's stock worth $27,226,000 after purchasing an additional 173,563 shares in the last quarter. Finally, Franklin Resources Inc. raised its stake in shares of Privia Health Group by 0.8% during the 4th quarter. Franklin Resources Inc. now owns 1,311,166 shares of the company's stock worth $25,633,000 after purchasing an additional 10,926 shares in the last quarter. Institutional investors own 94.48% of the company's stock.

Privia Health Group Stock Up 0.8%

PRVA traded up $0.19 during trading on Friday, hitting $25.09. The company's stock had a trading volume of 243,000 shares, compared to its average volume of 759,671. Privia Health Group, Inc. has a twelve month low of $15.92 and a twelve month high of $26.09. The stock's fifty day moving average price is $23.34 and its 200-day moving average price is $22.47. The firm has a market capitalization of $3.06 billion, a P/E ratio of 250.53, a PEG ratio of 3.47 and a beta of 0.87.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on PRVA. Truist Financial boosted their target price on Privia Health Group from $27.00 to $28.00 and gave the stock a "buy" rating in a report on Thursday, April 10th. Piper Sandler upped their price objective on Privia Health Group from $25.00 to $40.00 and gave the company an "overweight" rating in a report on Friday, February 28th. Needham & Company LLC reaffirmed a "buy" rating and issued a $30.00 price objective on shares of Privia Health Group in a report on Thursday, April 10th. Canaccord Genuity Group increased their target price on Privia Health Group from $29.00 to $30.00 and gave the stock a "buy" rating in a report on Friday, February 28th. Finally, Barclays increased their target price on Privia Health Group from $21.00 to $23.00 and gave the stock an "equal weight" rating in a report on Thursday, April 10th. One research analyst has rated the stock with a hold rating, eleven have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Buy" and a consensus price target of $27.38.

Insider Activity

In other Privia Health Group news, CEO Parth Mehrotra sold 15,100 shares of the business's stock in a transaction on Wednesday, April 30th. The stock was sold at an average price of $23.33, for a total value of $352,283.00. Following the transaction, the chief executive officer now owns 454,281 shares of the company's stock, valued at approximately $10,598,375.73. The trade was a 3.22% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO David Mountcastle sold 5,630 shares of the company's stock in a transaction on Wednesday, April 2nd. The shares were sold at an average price of $22.38, for a total value of $125,999.40. Following the transaction, the chief financial officer now directly owns 179,676 shares in the company, valued at $4,021,148.88. This represents a 3.04% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 51,579 shares of company stock worth $1,226,367 over the last quarter. 10.70% of the stock is currently owned by corporate insiders.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.